Group One Trading’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-74,339
Closed -$109K 8665
2022
Q2
$109K Buy
74,339
+60,100
+422% +$44.2K ﹤0.01% 4915
2022
Q1
$16K Sell
14,239
-3,300
-19% -$5.38K ﹤0.01% 6931
2021
Q4
$44K Buy
+17,539
New +$68.9K ﹤0.01% 6443
2021
Q2
Sell
-1,017
Closed -$8.57K 8763
2021
Q1
$9K Sell
1,017
-11,400
-92% -$118K ﹤0.01% 7099
2020
Q4
$135K Sell
12,417
-2,338
-16% -$28.8K ﹤0.01% 4347
2020
Q3
$176K Buy
14,755
+4,489
+44% +$60.1K ﹤0.01% 3755
2020
Q2
$165K Buy
+10,266
New +$179K ﹤0.01% 3546
2019
Q3
Sell
-4,993
Closed -$63K 5723
2019
Q2
$63K Buy
+4,993
New +$64.2K ﹤0.01% 3650
2019
Q1
Sell
-6
Closed -$67 5566
2018
Q4
$0 Sell
6
-1,099
-99% -$8.39K ﹤0.01% 5619
2018
Q3
$12K Buy
+1,105
New +$12.6K ﹤0.01% 4606
2017
Q3
Sell
-68
Closed -$1.04K 5317
2017
Q2
$1K Buy
+68
New +$1.03K ﹤0.01% 4665
2016
Q4
Sell
-2,966
Closed -$31K 4977
2016
Q3
$29K Buy
+2,966
New +$27.1K ﹤0.01% 3637
2016
Q2
Sell
-2,700
Closed -$30.1K 5050
2016
Q1
$33K Sell
2,700
-538
-17% -$5.44K ﹤0.01% 3485
2015
Q4
$52K Buy
3,238
+2,639
+441% +$39.1K ﹤0.01% 3387
2015
Q3
$8K Buy
599
+464
+344% +$9.36K ﹤0.01% 4384
2015
Q2
$3K Buy
135
+100
+286% +$1.92K ﹤0.01% 4629
2015
Q1
$1K Buy
+35
New +$723 ﹤0.01% 4663
2014
Q4
Sell
-37
Closed -$864 5399
2014
Q3
$1K Buy
+37
New +$1.15K ﹤0.01% 5023
2014
Q2
Sell
-13,364
Closed -$315K 5596
2014
Q1
$304K Buy
+13,364
New +$405K 0.01% 2097

Other funds holding EPZM

Group One Trading's EPZM Position: Q3 2022 in Review

Group One Trading sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 74,339 shares — an estimated $109K sold.

Group One Trading first reported a position in EPZM in Q1 2014 and held it in 19 quarters. The position peaked at $304K in Q1 2014. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Group One Trading reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 74,339 Epizyme, Inc shares in Q3 2022, an estimated $109K.
  • Group One Trading first reported a position in Epizyme, Inc in Q1 2014 and held it in 19 quarters.
  • Group One Trading's Epizyme, Inc position peaked at $304K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.